Opioid-Related Disorders

"Opioid-Related Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders related or resulting from abuse or mis-use of opioids.

Descriptor ID	D009293
MeSH Number(s)	C25.775.675 F03.900.675
Concept/Terms	Opioid-Related Disorders Opioid-Related Disorders Disorder, Opioid-Related Opioid Abuse Abuse, Opioid Abuses, Opioid Opioid Abuses Opiate Abuse Abuse, Opiate Abuses, Opiate Opiate Abuses Opiate Dependence Opiate Dependence Dependence, Opiate Opiate Addiction Addiction, Opiate

Below are MeSH descriptors whose meaning is more general than "Opioid-Related Disorders".

Diseases [C]
Chemically-Induced Disorders [C25]
Substance-Related Disorders [C25.775]
Opioid-Related Disorders [C25.775.675]
Psychiatry and Psychology [F]
Mental Disorders [F03]
Substance-Related Disorders [F03.900]
Opioid-Related Disorders [F03.900.675]

Below are MeSH descriptors whose meaning is related to "Opioid-Related Disorders".

Below are MeSH descriptors whose meaning is more specific than "Opioid-Related Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Opioid-Related Disorders" by people in this website by year, and whether "Opioid-Related Disorders" was a major or minor topic of these publications.

Bar chart showing 157 publications over 21 distinct years, with a maximum of 25 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	1	0	1
2004	1	0	1
2007	2	0	2
2008	5	1	6
2009	3	2	5
2010	2	0	2
2011	3	0	3
2012	4	0	4
2013	6	0	6
2014	8	1	9
2015	1	0	1
2016	2	0	2
2017	4	1	5
2018	5	2	7
2019	18	0	18
2020	24	1	25
2021	8	1	9
2022	9	0	9
2023	17	0	17
2024	14	4	18
2025	5	2	7

Below are the most recent publications written about "Opioid-Related Disorders" by people in Profiles.

Syvertsen J, Cabral A, Knaap E, Rey S, Pollini RA. The emergence of fentanyl in a stimulant landscape: Un/intentional use, social relations, and developing communities of care. Int J Drug Policy. 2025 Jun; 140:104807.

View in: PubMed
Tata V, Varisco TJ, Rinker DV, Abughosh S, Rhodes C, Thornton JD. Concurrent Depression Management in Patients with Opioid Use Disorder Undergoing Buprenorphine Therapy: Association with Buprenorphine Discontinuation. J Dual Diagn. 2025 Apr; 21(2):142-151.

View in: PubMed
Lovett K, Zatzick D, Palinkas LA, Engstrom A, Nye E, Field C, McGovern M, Parrish C, Banta-Green CJ, Whiteside LK. Adapting to the Fentanyl Epidemic: Rapid Qualitative Observations and Derived Clinical and Research Implications from the Emergency Department Longitudinal Integrated Care (ED-LINC) Randomized Clinical Trial. Psychiatry. 2025; 88(4):333-350.

View in: PubMed
Iscoe MS, Diniz Hooper C, Levy DR, Buchanan L, Dziura J, Meeker D, Taylor RA, D'Onofrio G, Oladele C, Sarpong DF, Paek H, Wilson FP, Heagerty PJ, Delgado MK, Hoppe J, Melnick ER. Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial. BMJ Open. 2025 Feb 20; 15(2):e098072.

View in: PubMed
Ovalles Lacruz A, Valle MS, Santoyo K, Clarke RD, Bhoite P, Alarcon LN. Empowering Future Physicians: Enhancing Naloxone Competency Through Early Harm Reduction Training in Medical Education. MedEdPORTAL. 2025; 21:11499.

View in: PubMed
Bernstein CN, Fisk JD, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Graff LA, Marrie RA. Psychiatric Comorbidity Does Not Enhance Prescription Opioid Use in Inflammatory Bowel Disease as It Does in the General Population. Inflamm Bowel Dis. 2025 Feb 10; 31(2):386-393.

View in: PubMed
Sharafshah A, Lewandrowski KU, Elman I, Baron D, Thanos PK, Hanna C, Gold MS, Badgaiyan RD, Cadet JL, Modestino EJ, Braverman ER, Dennen CA, Makale M, Sunder K, Murphy KT, Bowirrat A, Pinhasov A, Gondre-Lewis M, Gardner E, Sipple D, Jafari N, Zeine F, Khalsa J, Fiorelli RKA, Blum K. A Comprehensive 4-layered In Silico Pharmacogenomics Analysis of the Genetic Addiction Risk Severity (GARS) Test: Strong Genetic Evidence Supporting GARS as a Novel Personalized Pre-addiction Assessment Tool in the Opioid Crisis Era. Curr Pharm Biotechnol. 2025; 26(13):2153-2180.

View in: PubMed
Broussard G, Hohmeier KC, Field C, Gordon AJ, Carlston K, Cernasev A, Tyszko M, Snyder AM, Cochran G. Barriers and facilitators to the implementation of screening and intervention for co-use of opioid medications and alcohol among community pharmacy patients. J Subst Use Addict Treat. 2025 Feb; 169:209606.

View in: PubMed
Tatara E, Ozik J, Pollack HA, Schneider JA, Friedman SR, Harawa NT, Boodram B, Salisbury-Afshar E, Hotton A, Ouellet L, Mackesy-Amiti ME, Collier N, Macal CM. Agent-Based Model of Combined Community- and Jail-Based Take-Home Naloxone Distribution. JAMA Netw Open. 2024 12 02; 7(12):e2448732.

View in: PubMed
Balise RR, Hu MC, Calderon AR, Odom GJ, Brandt L, Luo SX, Feaster DJ. Data cleaning and harmonization of clinical trial data: Medication-assisted treatment for opioid use disorder. PLoS One. 2024; 19(11):e0312695.

View in: PubMed

People

Explore

Similar Concepts

Top Journals